View:
Mini BasicThis view is available after user registration.
ShortThis view is available when you buy a license.
StandardThis view is available when you buy a license.
CompleteThis view is available when you buy a license.
Bortezomib 1.3 / Rituximab 375 / Bendamustine 90, indolent B-Non-Hodgkin Lymphoma and Mantle Cell Lymphoma
Protocol-ID: 2678 V1.0 (Mini), BORT1.3/RITU375/BEND90, ind. B-NHL, MCLIndication(s)
- Mantle Cell Lymphoma; ICD-10 C83.1
- NHL, B-Cell Type, Follicular Grade I-IIIa; ICD-10 C82.9
- NHL, B-Cell Type, Marginal Zone Lymphoma; ICD-10 C83.0
 | The publishers and authors assume no liability for the accuracy of the contents. The application is at the own responsibility of the treating physician. ©Onkopti. |
Valid since: 19.08.2024